![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/436 | (2006.01) |
A61K 9/1623 | (2013.01) | ||
A61K 47/26 | (2006.01) | ||
A61P 11/00 | (2018.01) | ||
A61K 9/14 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61K 9/16 | (2006.01) | ||
A61K 9/0078 | (2013.01) | ||
A61K 31/445 | (2013.01) | ||
A61K 9/145 | (2013.01) | ||
A61K 31/436 | (2013.01) | ||
A61K 9/14 | (2013.01) | ||
A61K 47/26 | (2013.01) |
(11) | Patento numeris | 3738592 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20183293.8 |
Europos patento paraiškos padavimo data | 2014-10-07 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-11-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-01-26 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
201361888066 P | 2013-10-08 | US |
(72) |
ROTHBERG, Jonathan, M. , US
LICHENSTEIN, Henri , US
ARMER, Thomas , US
MELVIN, Jr Lawrence S. , US
|
(73) |
AI Therapeutics, Inc. ,
530 Old Whitfield Street, Guilford, CT 06437,
US
|
(54) | RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS |
RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS |